Drug application

TRILAFON (PERPHENAZINE)

Drugs@FDA NDA 011361 · SCHERING

Key facts

Drug name TRILAFON
Active ingredients PERPHENAZINE
Application type NDA
Application number 011361
Company SCHERING
Dosage forms TABLET, EXTENDED RELEASE, ORAL
Strength 8MG
Marketing status Discontinued
Reference listed drug No

At a glance

  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications